Quick Takeaways
- Casdin Capital, LLC filed SCHEDULE 13D/A for BioLife Solutions, Inc. Common Stock, $0.001 par value (BLFS).
- Disclosed ownership: 18%.
- Date of event: 07 Apr 2025.
Casdin Capital, LLC - 07 Apr 2025 SCHEDULE 13D/A Report for BioLife Solutions, Inc. Common Stock, $0.001 par value (BLFS)
- Filing Manager
- Casdin Capital, LLC
- Reporting Manager
- Casdin Capital, LLC
- Symbol
- BLFS
- Shares outstanding
- 47,217,076 shares
- Disclosed Ownership
- 8,735,159 shares
- Ownership
- 18%
- Form type
- SCHEDULE 13D/A
- Filing time
- 09 Apr 2025, 17:13:29 UTC
- Date of event
- 07 Apr 2025
- Next filing
- 12 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Casdin Capital, LLC disclosed 18% ownership in BioLife Solutions, Inc. Common Stock, $0.001 par value (BLFS) on 07 Apr 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 09 Apr 2025, 17:13.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Casdin Capital, LLC | 18% | 8,735,159 | 0 | 8,735,159 | By: /s/ Eli Casdin* | Eli Casdin, Managing Member | 0001534261 |
| Casdin Partners Master Fund, L.P. | 18% | 8,735,159 | 0 | 8,735,159 | By: /s/ Eli Casdin* | Eli Casdin, Managing Member of its General Partner | |
| Casdin Partners GP, LLC | 18% | 8,735,159 | 0 | 8,735,159 | By: /s/ Eli Casdin* | Eli Casdin, Managing Member | |
| Eli Casdin | 18% | 8,735,159 | 0 | 8,735,159 | By: /s/ Eli Casdin* | Eli Casdin |